echnologies'
annual meeting of stockholders, as filed with the S.E.C. on a Schedule 14A.
Information about the directors and executive officers of Tutogen and their
ownership of Tutogen common stock is set forth in Tutogen's Annual Report
on Form 10-K for the fiscal year ended September 30, 2007. Additional
information regarding the interests of those participants and other persons
who may be deemed participants in the merger may be obtained by reading the
joint proxy statement/prospectus regarding the proposed merger filed with
the S.E.C. on January 23, 2008. You may obtain free copies of these
documents as described in the preceding paragraph.
Tutogen Medical, Inc.
Consolidated Statement of Income (Loss)
(In Thousands, Except for Share and Per Share Data)
Three Months Ended
December 31,
2007 2006
Revenue $ 14,955 $ 11,463
Cost of revenue 6,888 4,421
Gross profit 8,067 7,042
Operating Expenses
General and administrative 4,210 2,362
Distribution and marketing 4,553 3,441
Research and development 617 527
Total Operating Expenses 9,380 6,330
Operating (loss) income (1,313) 712
Foreign exchange loss (3) (38)
Interest and other income 130 34
Interest and other expense (86) (274)
'/>"/>
SOURCE Tutogen Medical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference2.
Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products3.
Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products4.
Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results5.
Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results6.
Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation7.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound8.
QMed, Inc. Reports July Medicare SNP Enrollments9.
Phlo Affiliate Reports Expanded Coverage to Oregon Border10.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results11.
Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007